Lv3
207 积分 2022-12-10 加入
Mapping and engineering the human cell–cell interactome
3天前
已完结
Integrated experimental and AI innovations for RNA structure determination
3天前
已完结
Ethical principles for the use of human cellular biotechnologies
3天前
已完结
免疫检查点抑制剂用于进展期胃癌围手术期治疗的中国专家共识
11天前
已完结
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
29天前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
1个月前
已完结
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
1个月前
已完结
皖公网安备34019202002308
